VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DMRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DMRADamora Therapeutics, Inc.
$22.56$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDMRAFinancials

Damora Therapeutics, Inc. (DMRA) Income Statement

8Y historyFree accessUpdated daily

Damora Therapeutics, Inc. (DMRA) annual income statement — 8-year revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

DMRA Income Statement

Annual statement

DMRA Income Statement

Damora Therapeutics, Inc. (DMRA) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Sales/Revenue000000000
Revenue Growth %---------
Cost of Goods Sold79K0181K830K490K441K188K111K0
COGS % of Revenue---------
Gross Profit-79K0-181K-830K-490K-441K-188K-111K0
Gross Margin %---------
Gross Profit Growth %-100%78.19%-69.39%-11.11%-134.57%-69.37%--
Operating Expenses304.29M210.87M16.72M35.63M60.72M51.79M33.45M38.86M12.91M
OpEx % of Revenue---------
Selling, General & Admin31.93M9.69M10.32M11.86M12.51M13.3M8.82M2.33M2.81M
SG&A % of Revenue---------
Research & Development272.42M201.19M6.4M23.77M48.21M38.49M24.63M36.53M10.09M
R&D % of Revenue---------
Other Operating Expenses000000000
Operating Income-304.36M-210.87M-16.9M-36.46M-61.21M-52.23M-33.64M-38.97M-12.91M
Operating Margin %---------
Operating Income Growth %--1147.98%53.65%40.44%-17.19%-55.27%13.69%-201.94%-
EBITDA-304.01M-210.84M-16.72M-35.63M-60.72M-51.79M-33.45M-38.86M-12.91M
EBITDA Margin %---------
EBITDA Growth %-2465.3%-1161.29%53.08%41.32%-17.25%-54.82%13.92%-201.08%-
D&A (Non-Cash Add-back)350K34K181K830K490K441K188K111K0
EBIT-300.29M-209.79M-21.4M-38.35M-61.62M-51.75M-33.64M-38.97M-12.91M
Net Interest Income12.29M1.17M844K1.69M722K156K00-2.97M
Interest Income12.29M1.17M844K1.69M722K156K000
Interest Expense000000002.97M
Other Income/Expense13.02M1.08M-4.5M-1.89M-417K475K-1.2M2.46M-2.96M
Pretax Income-291.34M-209.79M-21.4M-38.35M-61.62M-51.75M-34.84M-36.51M-15.87M
Pretax Margin %---------
Income Tax341K50K41K000000
Effective Tax Rate %-0.12%-0.02%-0.19%0%0%0%0%0%0%
Net Income-291.68M-209.84M-21.44M-38.35M-61.62M-51.75M-34.84M-36.51M-15.87M
Net Margin %---------
Net Income Growth %-1740.97%-878.77%44.09%37.77%-19.08%-48.55%4.57%-130.05%-
Net Income (Continuing)-291.68M-209.84M-21.44M-38.35M-61.62M-51.75M-34.84M-36.51M-15.87M
Discontinued Operations000000000
Minority Interest000000000
EPS (Diluted)-17.82-152.99-18.53-36.08-60.63-51.22-34.48-41.35-18.68
EPS Growth %-915.04%-725.63%48.64%40.49%-18.37%-48.55%16.61%-121.36%-
EPS (Basic)--152.99-18.53-36.08-60.63-51.22-34.48-41.35-18.68
Diluted Shares Outstanding16.37M1.36M1.16M1.06M1.02M1.01M1.01M1.02M1.02M
Basic Shares Outstanding16.37M1.36M1.16M1.06M1.02M1.01M1.01M1.02M1.02M
Dividend Payout Ratio---------

DMRA — Frequently Asked Questions

Quick answers to the most common questions about buying DMRA stock.

What was Damora Therapeutics, Inc.'s (DMRA) revenue in 2025?

For fiscal year 2025, Damora Therapeutics, Inc. (DMRA) reported total revenue of $0.0M.

Is Damora Therapeutics, Inc. (DMRA) profitable?

Damora Therapeutics, Inc. (DMRA) reported a net loss of $209.8M for the fiscal year ending 2025.